Congressional Oversight Manual, and More from CRS
The purposes, authorities, and instruments of congressional oversight are described in detail in a newly-expanded Congressional Oversight Manual (pdf) prepared by the Congressional Research Service.
“Congressional oversight and investigations can often, though not always, become adversarial,” the CRS Manual observes. “This is especially true when the entity being targeted, whether a private individual, corporation, or executive branch agency, has information Congress believes is necessary to its inquiry but refuses to disclose. In those situations the targeted entity may attempt to use several methods of avoiding disclosure. A commonly used tactic to avoid disclosure is to assert that the information cannot be disclosed due to a specific law, rule, or executive decision. Another common tactic is to assert that the information itself is of such a sensitive nature that Congress is not among those entities entitled or authorized to have the information.”
The Manual proceeds to scrutinize the validity of such tactics, and discusses the options available to Congress to compel disclosure. A copy was obtained by Secrecy News. See Congressional Oversight Manual, Congressional Research Service, 168 pages, January 6, 2011.
Other noteworthy new CRS reports include the following (both pdf).
National Security Letters in Foreign Intelligence Investigations: A Glimpse of the Legal Background and Recent Amendments, December 27, 2010.
Ricin: Technical Background and Potential Role in Terrorism, December 21, 2010.
Often negotiations between data center developers and local officials are conducted behind closed doors, protected by NDAs. How can we have an informed debate, when we don’t know what’s on the table?
As federal data policy nerds, the question we get asked all the time is “How much data has the current administration terminated?”
Google’s motto famously used to be “don’t be evil.” However, its latest feature has just made being evil a whole lot easier.
The public will judge the next era of American science by the innovation that touches their lives through the new cures, products, and opportunities created within their communities.